2016 Europe Pap Smear/HPV Market: Emerging Opportunities, Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Landscape--France, Germany, Italy, Spain, UK

Publisher Name :
Date: 14-Sep-2016
No. of pages: 240
Inquire Before Buying

Complete report $2,850.  DataPack (test volumes, sales forecasts) $1,850. This report presents a detailed analysis of the Pap Smear/HPV testing market in Europe (France, Germany, Italy, Spain, UK), including clinical significance and current laboratory practice; as well as five-year test volume and sales forecasts by country and market segment.

The report examines market applications of DNA probes, biochips/microarrays, monoclonal antibodies, immunoassays, IT, chromosome analysis, and other technologies; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide. Contains 240 pages and 16 tables

2016 Europe Pap Smear/HPV Market: Emerging Opportunities, Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Landscape--France, Germany, Italy, Spain, UK

Table of Contents

I. Introduction
II. PAP Smear/HPV Worldwide Market and Technology Overview
A. PAP Smear/HPV: Clinical Significance and Laboratory Practices
B. Instrumentation Review And Market Needs
1. Abbott AxSYM
2. Abbott Architect c4000
3. Abbott Architect i2000 Series
4. Abbott Architect ci8200 System
5. Beckman Coulter UniCel Series
6. Beckman Coulter Access
7. Binding Site ESP600
8. bioMerieux Mini Vidas
9. Carolina Chemistries BioLis 24i
10. DiaSorin Liaison
11. Horiba ABX Pentra 400
12. Inverness DS2
13. J&J Vitros ECi/ECiQ
14. J&J Vitros 3600
15. J&J Vitros 5600
16. Olympus AU5400
17. Olympus AU3000i
18. Olympus AU2700
19. Roche Modular Analytics
20. Roche Cobas Integra 400
21. Roche Cobas Integra 400 Plus
22. Roche Elecsys
23. Roche Cobas c311
24. Siemens ADVIA Centaur
25. Siemens Dimension
26. Siemens Dimension RxL Max
27. Siemens Dimension Vista 500
28. Siemens Immulite
29. Siemens Stratus
30. Tosoh AIA-Series
31. Vital Diagnostics ATAC 8000
32. Vital Diagnostics Envoy 500
C. Current and Emerging Technologies
1. Monoclonal and Polyclonal Antibodies
2. Immunoassays
a. Technological Principle
b. Radioimmunoassay (RIA)
c. Enzyme Immunoassays (EIA)
- Overview
- ELISA
- Immunofiltration
- Particle-Membrane Capture Immunoassay
- Enzyme Amplification
d. Fluorescent Immunoassays
e. Luminescence
- Chemiluminescence
- Bioluminescence
f. Latex Agglutination
g. Immunoprecipitation
H. Affinity Chromatographu
e. Liposome Flow-Injection Immunoassay
3. Molecular Diagnostics
a. Technology Overview
b. Amplification Methods
- PCR
- DAP-PCR
- Immuno-PCR
- QC-PCR
- CAR
- DNA
- HPA
- LCR
- NASBA
- QBR
- SDA
- 3 SR, and others
4. Chromosome Analysis
a. Chronic Myelogenous Leukemia (CML)
b. Acute Myeloid Leukemia (AML)
c. Acute Lymphoblastic Leukemia (ALL)
d. Malignant Lymphomas
Lymphoid Malignancies
e. Chronic Lymphocytic Leukemia (CLL)
f. Solid Cancers
g. Chromosomal Translocation and Oncogenes
5. Artificial Intelligence
6. Flow Cytometry
7. Two Dimensional Gel Electrophoresis (2-DGE)
8. Biosensors
9. Competing/Complementing Technologies
a. CT
b. MRI
c. NMR
d. PET
e. Photonics Spectroscopy
D. Personal Testing
III. France: Test Volume and Diagnostics Sales Forecast by Market Segment, Supplier Sales and Market Shares
IV. Germany: Test Volume and Diagnostics Sales Forecast by Market Segment, Supplier Sales and Market Shares
V. Italy: Test Volume and Diagnostics Sales Forecast by Market Segment, Supplier Sales and Market Shares
VI. Spain: Test Volume and Diagnostics Sales Forecast by Market Segment, Supplier Sales and Market Shares
VII. U.K.: Test Volume and Diagnostics Sales Forecast by Market Segment, Supplier Sales and Market Shares
VIII. Design Criteria for Decentralized Testing Products
IX. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation Factor
X. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XI. Competitive Profiles
- Abbott
- AdnaGen
- Agilent Technologies
- Applied Gene Technologies
- Arca Biopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biomedical Diagnostics/Theradiag
- bioMerieux
- Bio-Rad
- CellSearch
- Cepheid
- Decode Genetics
- Diadexus
- Diagnocure
- Diasorin
- Eiken Chemical
- Elitech Group
- Epigenomics
- Enterix/Clinical Genomics
- Enzo Biochem
- Exact Sciences
- Fujirebio/Innogenetics
- Guided Therapeutics
- Hologic/Gen-Probe
- Kreatech/Leica
- Kyowa Medex
- Life Technologies
- Mackay Life Sciences
- Myriad Genetics
- OncoLab
- Ortho-Clinical Diagnostics
- Panacea Pharmaceuticals
- Polartechnics
- Polymedco
- PreMD
- Qiagen
- Quest Diagnostics
- Radient Pharmaceuticals
- Roche
- Scienion
- Sequenom
- Siemens Healthcare
- Takara Bio
- Targeted Diagnostics & Therapeutics
- Tosoh
- Veridex
- Vermillion
- Wako Pure Chemicals
- Wallac/PE
- Zila

List of Tables

Major Companies Developing or Marketing Pap Smear/HPV Tests
France PAP Smear Test Volume and Diagnostics Sales by Market Segment
France Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
France PAP Smear/HPV Diagnostic Testing Market Sales and Shares of Leading Suppliers
Germany PAP Smear Test Volume and Diagnostics Sales by Market Segment
Germany Papillomavirus(HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
Germany PAP Smear/HPV Diagnostic Testing Market Sales and Shares of Leading Suppliers
Italy PAP Smear Test Volume and Diagnostics Sales by Market Segment
Italy Papillomavirus(HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
Italy PAP Smear/HPV Diagnostic Testing Market Sales and Shares of Leading Suppliers
Spain PAP Smear Test Volume and Diagnostics Sales by Market Segment
Spain Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
Spain PAP Smear/HPV Diagnostic Testing Market Sales and Shares of Leading Suppliers
U.K. PAP Smear Test Volume and Diagnostics Sales by Market Segment
U.K. Papillomavirus(HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. PAP Smear/HPV Diagnostic Testing Market Sales and Shares of Leading Suppliers
  • EMEA (Europe, Middle East and Africa) Cancer Diagnostics Market Report 2017
    Published: 21-Jun-2017        Price: US 4000 Onwards        Pages: 102
    In this report, the EMEA Cancer Diagnostics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Cancer Diagnostics for these regions, from 2012 to 2022 (forecast) - Europe: Germany, France, UK, Russia, Italy and Benelux;......
  • United States PSA Test Market by Manufacturers, States, Type and Application, Forecast to 2022
    Published: 19-Jun-2017        Price: US 4480 Onwards        Pages: 122
    Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), is a glycoprotein enzyme encoded in humans by the KLK3 gene. The PSA test measures the level of PSA in a man's blood. For this test, a blood sample is sent to a laboratory for analysis. The results are usually reported as nanograms of PSA per milliliter (ng/mL) of blood. Scope of the Report: This report focuses on the PSA Test in United States market, to split t......
  • Asia-Pacific Prostate Cancer Diagnostics Market by Manufacturers, Regions, Type and Application, Forecast to 2022
    Published: 16-Jun-2017        Price: US 4480 Onwards        Pages: 119
    The prostate is a walnut-sized gland located behind the base of a man's penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread. Prostate Cancer Diagnostics refers to using PSA, rectal exam, biopsy and ......
  • United States Cancer Diagnostics Market Report 2017
    Published: 13-Jun-2017        Price: US 3800 Onwards        Pages: 96
    In this report, the United States Cancer Diagnostics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth rate ......
  • United States HPV Testing Market by Manufacturers, States, Type and Application, Forecast to 2022
    Published: 06-Jun-2017        Price: US 4480 Onwards        Pages: 122
    The human papillomavirus (HPV) test detects the presence of human papillomavirus, a virus that can lead to the development of genital warts, abnormal cervical cells or cervical cancer. The HPV testing is further classified into three sub-segments, namely, follow-up testing, co-testing, HPV primary testing. Scope of the Report: This report focuses on the HPV Testing in United States market, to split the market based on manufacturers, states, type and application.......
  • Global Cancer Diagnostics Market Research Report 2017
    Published: 05-Jun-2017        Price: US 2900 Onwards        Pages: 102
    In this report, the global Cancer Diagnostics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Cancer Diagnostics in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China ......
  • Global and Chinese Cancer/Tumor Profiling Industry, 2017 Market Research Report
    Published: 03-Jun-2017        Price: US 3000 Onwards        Pages: 150
    The 'Global and Chinese Cancer/Tumor Profiling Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Cancer/Tumor Profiling industry with a focus on the Chinese market. The report provides key statistics on the market status of the Cancer/Tumor Profiling manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, the report provides a basic overview of the industry......
  • North America PSA Test Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 17-May-2017        Price: US 4480 Onwards        Pages: 122
    Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), is a glycoprotein enzyme encoded in humans by the KLK3 gene.The PSA test measures the level of PSA in a man's blood. For this test, a blood sample is sent to a laboratory for analysis. The results are usually reported as nanograms of PSA per milliliter (ng/mL) of blood.Scope of the Report:This report focuses on the PSA Test in North America market, especially in United States, Can......
  • United States Prostate Cancer Diagnostics Market by Manufacturers, States, Type and Application, Forecast to 2022
    Published: 16-May-2017        Price: US 4480 Onwards        Pages: 119
    The prostate is a walnut-sized gland located behind the base of a man's penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread.Prostate Cancer Diagnostics refers to using PSA, rectal exam, biopsy and others to dia......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs